Tìm kiếm thay thế:
"dao open" » "ao open" (Mở rộng tìm kiếm), "caso open" (Mở rộng tìm kiếm), "two open" (Mở rộng tìm kiếm), "daao open" (Mở rộng tìm kiếm), "dao opens" (Mở rộng tìm kiếm), "da1 open" (Mở rộng tìm kiếm)
"so open" » "ao open" (Mở rộng tìm kiếm), "caso open" (Mở rộng tìm kiếm), "two open" (Mở rộng tìm kiếm), "sao open" (Mở rộng tìm kiếm), "so opens" (Mở rộng tìm kiếm), "s1 open" (Mở rộng tìm kiếm)
"do open" » "two open" (Mở rộng tìm kiếm), "oto open" (Mở rộng tìm kiếm), "dao open" (Mở rộng tìm kiếm), "do opens" (Mở rộng tìm kiếm), "d1 open" (Mở rộng tìm kiếm)
"esmo open" » "esmao open" (Mở rộng tìm kiếm), "esmo opens" (Mở rộng tìm kiếm), "esm1 open" (Mở rộng tìm kiếm)
"o open" » "ao open" (Mở rộng tìm kiếm), "o opens" (Mở rộng tìm kiếm), "1 open" (Mở rộng tìm kiếm)
Đang hiển thị 1 - 20 kết quả của 1,029 cho tìm kiếm '(("esmo open") OR ((((("so open") OR ("do open"))) OR ((("o open") OR ("dao open"))))))', thời gian truy vấn: 1.34s Tinh chỉnh kết quả
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
ESMO Open—Cancer Horizons and the future of oncology

CSCO joins ESMO Open—Cancer Horizons
ESMO Open: news in breast cancer 2019

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
ESMO Open special series on new emerging targets in cancer immunotherapy

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
One year of ESMO Open: Cancer Horizons—where are we going from here?

Plasmodesmata. A Not So Open-and-Shut Case
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
Desafios do Open Design

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Adoção do Open Peer Review
How do Openers Contribute to Student Learning?

Criptografia digital: implementação do OpenPGP
Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Công cụ tìm kiếm: Nhận nguồn cấp dữ liệu RSS — Tìm kiếm email này — Lưu tìm kiếm